Gyula Simig

Method for the production of lumateperone and its salts

Method for the production of lumateperone and its salts

PROCESS FOR THE PRODUCTION OF OZANIMOD

Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them

Pharmaceutical intermediates and process for the preparation thereof

Method for the preparation of high-purity pharmaceutical intermediates

2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES

Crystalline form I rosuvastatin zinc salt

Process for the preparation of rosuvastatin salts

PROCESS FOR PREPARATION OF HIGH-PURITY MELOXICAM AND MELOXICAM POTASSIUM SALT

Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof

3,4-DIHYDROBENZO[1,2,3]THIADIAZINE-1,1-DIOXIDE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, MEDICAMENTS CONTAINING SAID DERIVATIVES AND THEIR USE

BENZO[1,2,3]THIADIAZINE DERIVATES

Medicament for the enhancement of cognitive function and neuroprotection

PYRIDINE DERIVATIVES OF ALKYL OXINDOLES AS 5-HT7 RECEPTOR ACTIVE AGENTS

Rosuvastatin zinc salt

INDOL-2-ONE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS DISORDERS, GASTROINTESTINAL DISORDERS AND CARDIOVASCULAR DISORDERS

Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates

Process for preparation of high-purity meloxicam and meloxicam potassium salt

DULOXETINE SALTS

Aripiprazole Salts

Donepezil Salts Suitable for the Preparation of Pharmaceutical Compositions

Piperazine derivatives of alkyl oxindoles

8-chloro-2,3-benzodiazepine derivatives

Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions

Pyridine Derivatives of Alkyl Oxindoles as 5-Ht7 Receptor Active Agents

Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders

Piperazine derivatives of dialkyl oxindoles

Piperazine Derivatives Of Alkyl Oxindoles

Process for the preparation of high purity perindopril

Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug

Process for the preparation of amorphous form of a platelet aggregation inhibitor drug

2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient

Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin

Polymorphs of olanzapine hydrochloride

Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions

2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient

Method for synthesis of (2S, 3aS, 7aS)-1-{(S)-alanyl}-octahydro-1-indole-2-carboxylic acid derivatives and use for synthesis of perindopril

2,3-benzodiazepine derivatives

Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds

Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same

Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor

Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds

Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same